Anti obese potential of Triphala Madhupaka

Phase 2

Not yet recruiting

Conditions: Overweight,

Registration Number: CTRI/2019/09/021087

Lead Sponsor: Dr Madan Kumar S D

Brief Summary: Ayurveda recommended intake of food articles that which maintain the health and prevent un manifested diseases. An ancient balanced diet consists of food articles which are listed in Nithyasevaniyaahara. Madhu is one among the nithyasevaniyaahara. It has medohara and lakshanas effect when it is one year old. Obesityis a medical condition in which excess body fat accumulates to an extent that it may have a negative effect on health. Obesity increases the likely hood of various diseases, particularly heart disease, type 2 diabetes, obstructive sleep apnoea, certain types of cancer, and osteoarthritis. Obesity is most commonly caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility.Worldwide obesity has nearly tripled since 1975.In 2016, more than 1.9 billion adults, 18 years and older, were overweight Of these over 650 million were obese.39% of adults aged 18 years and over were overweight in 2016, and 13% were obese. Most of the worldâ€™s population in countries where overweight and obesity kills more people than underweight. Ayurveda emphasizes the use of Purana Madhu as a nutritional therapy in Sthoulya. Triphala is another drug used in combination for the same. Triphala Madhupaka is experimentally analysed for its, in-vitro anti-obese action and found to be safe for oral consumption. But it is not clinically proven hence, in this study Triphala Madhupaka will be used to assess its anti-obese action..

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

Ready to give informed return consent.

Exclusion Criteria

Obesity due to secondary causes PCOD Hypothyroidism History of steroidal or hormonal therapy, oral contraception Patients suffering from chronic metabolic disorders Subjects with mental illness.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All the patients who fit in inclusion criteria will be given treatment with Triphala Madhupaka 6gm twice daily before food	will be assessing on baseline treatment, 15th day and on 30th day

Secondary Outcome Measures

Name	Time	Method
Quality of life	will be assessing on baseline treatment, 15th day and on 30th day

Trial Locations

Locations (1): Sri Dharmasthala Manjunatheshwara
🇮🇳
Hassan, KARNATAKA, India
Sri Dharmasthala Manjunatheshwara
🇮🇳Hassan, KARNATAKA, India
Dr Madan Kumar S D
Principal investigator
9743620410
madangowda1993@gmail.com